— Know what they know.
Not Investment Advice
Also trades as: NXGL (NASDAQ) · $vol 0M

NXGLW NASDAQ

NEXGEL, Inc.
1W: +12.1% 1M: +13.0% 3M: -48.7% YTD: -93.7% 1Y: -95.4% 3Y: -94.4%
$0.01
+0.00 (+13.93%)
 
Weekly Expected Move ±30.9%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 41 · $1.1M mcap · 62M float · 0.013% daily turnover · Short 28% of daily vol

Supply Chain Overview

12 relationships
11
As Filer
counterparties named
1
As Counterparty
mentioned by others
5
Rel. Types
2021-03-17
Earliest Filing
2026-03-10
Latest Filing
partner: 3 target: 3 licensee: 2 acquirer: 2 investor: 1

Counterparties (Filed by NXGLW)

11 relationships

Companies named in NXGLW's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Celularity Inc. CELUW licensee Licensor granting asset purchase and exclusive license 2026-03-10 View
NexGel, Inc. NXGLW licensee Licensee acquiring assets and receiving exclusive license 2026-03-10 View
Celeniv Pte. Ltd. — partner Master Licensor of the underlying patent rights 2026-03-10 View
NexGel, Inc. NXGLW acquirer Buyer purchasing eyeliner and lash business assets 2024-05-20 View
Semmens Online Pty Ltd — target Trustee for Semmens Business Trust selling eyeliner and lash business assets 2024-05-20 View
Semmens Business Trust — target Beneficiary of Semmens Online Pty Ltd selling eyeliner and lash business assets 2024-05-20 View
NexGel, Inc. NXGLW acquirer Buyer purchasing assets of Kenkoderm skincare line 2023-12-05 View
Olympus Trading Company, LLC — target Seller of Kenkoderm skincare line assets 2023-12-05 View
Maxim Group LLC MMS partner Underwriter for the public offering of common stock and warrants 2021-12-27 View
Continental Stock Transfer & Trust Company — partner Transfer agent for the warrants issued in the offering 2021-12-27 View
Auctus Fund, LLC — investor Issued senior secured convertible promissory note and warrants to NexGel, Inc. 2021-03-17 View

Mentioned As Counterparty

1 mentions

Other companies that named NXGLW in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
CELUW Celularity Inc licensee Licensee acquiring assets and receiving exclusive license 2026-03-10 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-24 Regulation FD; Exhibits View
2026-09-23 Shareholder Vote; Exhibits View
2026-08-21 Officer/Director Change; Exhibits View
2026-08-17 Earnings Release; Exhibits View
2026-08-05 Shareholder Vote; Exhibits View
2026-07-29 Officer/Director Change; Exhibits View
2026-07-09 Other Events View
2026-07-02 Officer/Director Change View
2026-06-17 Regulation FD; Exhibits View
2026-05-15 Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits Agreement View
2026-05-12 Officer/Director Change; Other Events; Exhibits View
2026-04-30 Officer/Director Change; Other Events; Exhibits View
2026-04-24 Delisting Notice View
2026-04-21 Material Agreement; Acquisition/Disposition; Financial Obligation; Unregistered Equity Sales; Other Agreement Acquisition View
2026-03-10 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2026-02-11 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2026-01-30 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2026-01-07 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-12-11 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-11-24 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms